
MDMA-assisted therapy for PTSD: where it stands after the 2024 FDA rejection
Lykos Therapeutics' MDMA application was declined by the FDA in August 2024. After the April 2026 executive order, the resubmission is now eligible for a Priority Voucher. Here is what actually changed and the realistic path to approval.
u/Firefly5647 — 3 days ago